417 related articles for article (PubMed ID: 17073861)
1. Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model.
Metzsch C; Liao Q; Steen S; Algotsson L
Acta Anaesthesiol Scand; 2007 Jan; 51(1):86-93. PubMed ID: 17073861
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan cardioprotection in acutely beta-1 adrenergic receptor blocked open chest pigs.
Metzsch C; Linnér R; Steen S; Liao Q; Algotsson L
Acta Anaesthesiol Scand; 2010 Jan; 54(1):103-10. PubMed ID: 19681782
[TBL] [Abstract][Full Text] [Related]
3. Myocardial glycerol release, arrhythmias and hemodynamic instability during regional ischemia-reperfusion in an open chest pig model.
Metzsch C; Liao Q; Steen S; Algotsson L
Acta Anaesthesiol Scand; 2006 Jan; 50(1):99-107. PubMed ID: 16451157
[TBL] [Abstract][Full Text] [Related]
4. Milrinone and levosimendan during porcine myocardial ischemia -- no effects on calcium overload and metabolism.
Axelsson B; Johansson G; Abrahamsson P; Gupta A; Tydén H; Wouters P; Haney M
Acta Anaesthesiol Scand; 2013 Jul; 57(6):719-28. PubMed ID: 23517167
[TBL] [Abstract][Full Text] [Related]
5. Anti-ischemic effects of inotropic agents in experimental right ventricular infarction.
Hein M; Roehl AB; Baumert JH; Scherer K; Steendijk P; Rossaint R
Acta Anaesthesiol Scand; 2009 Aug; 53(7):941-8. PubMed ID: 19426242
[TBL] [Abstract][Full Text] [Related]
6. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
[TBL] [Abstract][Full Text] [Related]
7. A dose-response study of levosimendan in a porcine model of acute ischaemic heart failure.
Kolseth SM; Wahba A; Kirkeby-Garstad I; Aro S; Nordgaard H; Høydal M; Rognmo Ø; Nordhaug D
Eur J Cardiothorac Surg; 2012 Jun; 41(6):1377-83. PubMed ID: 22219475
[TBL] [Abstract][Full Text] [Related]
8. Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and myocardial stunning in pigs.
Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
Acta Anaesthesiol Scand; 2008 Mar; 52(3):397-405. PubMed ID: 18269389
[TBL] [Abstract][Full Text] [Related]
9. Modulation of programmed forms of cell death by intracoronary levosimendan during regional myocardial ischemia in anesthetized pigs.
Grossini E; Caimmi PP; Platini F; Molinari C; Uberti F; Cattaneo M; Valente G; Mary DA; Vacca G; Tessitore L
Cardiovasc Drugs Ther; 2010 Feb; 24(1):5-15. PubMed ID: 20162343
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
Du Toit EF; Muller CA; McCarthy J; Opie LH
J Pharmacol Exp Ther; 1999 Aug; 290(2):505-14. PubMed ID: 10411556
[TBL] [Abstract][Full Text] [Related]
11. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
Givertz MM; Andreou C; Conrad CH; Colucci WS
Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544
[TBL] [Abstract][Full Text] [Related]
12. Direct protective effects of dexmedetomidine against myocardial ischemia-reperfusion injury in anesthetized pigs.
Yoshitomi O; Cho S; Hara T; Shibata I; Maekawa T; Ureshino H; Sumikawa K
Shock; 2012 Jul; 38(1):92-7. PubMed ID: 22552015
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of levosimendan in the early stages of endotoxemia.
Cunha-Goncalves D; Perez-de-Sa V; Dahm P; Grins E; Thörne J; Blomquist S
Shock; 2007 Jul; 28(1):71-7. PubMed ID: 17510599
[TBL] [Abstract][Full Text] [Related]
14. Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model.
Leprán I; Pollesello P; Vajda S; Varró A; Papp JG
J Cardiovasc Pharmacol; 2006 Oct; 48(4):148-52. PubMed ID: 17086092
[TBL] [Abstract][Full Text] [Related]
15. Effects of levosimendan on myocardial infarct size and hemodynamics in a closed-chest porcine ischemia-reperfusion model.
Busk M; Maeng M; Kristensen J; Berg JS; Mortensen UM; Nielsen TT; Nielsen-Kudsk JE
Cardiovasc Drugs Ther; 2006 Oct; 20(5):335-42. PubMed ID: 17122904
[TBL] [Abstract][Full Text] [Related]
16. Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake.
Michaels AD; McKeown B; Kostal M; Vakharia KT; Jordan MV; Gerber IL; Foster E; Chatterjee K
Circulation; 2005 Mar; 111(12):1504-9. PubMed ID: 15781741
[TBL] [Abstract][Full Text] [Related]
17. Calpain inhibition reduces infarct size and improves global hemodynamics and left ventricular contractility in a porcine myocardial ischemia/reperfusion model.
Khalil PN; Neuhof C; Huss R; Pollhammer M; Khalil MN; Neuhof H; Fritz H; Siebeck M
Eur J Pharmacol; 2005 Dec; 528(1-3):124-31. PubMed ID: 16324693
[TBL] [Abstract][Full Text] [Related]
18. Inotropic, vasodilating and preconditioning actions of levosimendan in the heart.
Meyer K; Schipke JD; Klocke RC; Gams E; Korbmacher B
Thorac Cardiovasc Surg; 2008 Oct; 56(7):379-85. PubMed ID: 18810693
[TBL] [Abstract][Full Text] [Related]
19. Intracoronary levosimendan prevents myocardial ischemic damages and activates survival signaling through ATP-sensitive potassium channel and nitric oxide.
Caimmi PP; Molinari C; Uberti F; Micalizzi E; Valente G; Mary DA; Vacca G; Grossini E
Eur J Cardiothorac Surg; 2011 Apr; 39(4):e59-67. PubMed ID: 21247774
[TBL] [Abstract][Full Text] [Related]
20. Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure.
Segreti JA; Marsh KC; Polakowski JS; Fryer RM
J Pharmacol Exp Ther; 2008 Apr; 325(1):331-40. PubMed ID: 18171907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
